|
Thalidomide-4-NH-PEG1-NH-Boc
|
|
2154342-17-1
|
|
|
標(biāo)準(zhǔn)品RN1333
|
2361119-87-9
|
|
Edoxaban impurity 13
|
|
1243308-37-3
|
|
Fosaprepitant impurity 7
|
|
172822-01-4
|
|
Gemcitabine impurity 8
|
|
2174019-90-8
|
|
Oxymetazoline EP Impurity B
|
|
526-36-3
|
|
Gemcitabine impurity 9
|
|
122111-02-8
|
|
Avatrombopag impurity 34
|
|
54127-29-6
|
|
Vancomycin EP Impurity A
|
|
91700-98-0
|
|
Vancomycin Impurity 1
|
|
155386-25-7
|
|
3-oxobutanal
|
乙酰乙醛
|
625-34-3
|
|
28-epi-Rapamycin
|
|
253431-35-5
|
|
Avatrombopag impurity 35
|
|
570403-04-2
|
|
Avatrombopag impurity 43
|
|
931395-73-2
|
|
Fosaprepitant impurity 5
|
|
1185503-00-7
|
|
1-(pyridin-4-yl)urea
|
|
13262-38-9
|
|
Gadobutrol Impurity 7
|
|
54364-78-2
|
|
Rosuvastatin Impurity 9
|
|
2375865-91-9
|
|
Gemcitabine impurity 6
|
|
134877-43-3
|
|
VH032-NH-CO-CH2-NH2
|
|
2010986-20-4
|
|
Bromoacetaldehyde
|
溴乙醛
|
17157-48-1
|
|
Cefditoren sodium
|
|
104146-53-4
|
|
Trifluridine Impurity 4
|
|
362607-81-6
|
|
Medetomidine Impurity 20
|
|
104245-83-2
|
|
Avatrombopag impurity 8
|
阿伐曲泊帕雜質(zhì)8
|
677007-73-7
|
|
Moxifloxacin impurity 3
|
|
2445515-66-0
|
|
(Z)-Methyl 3-Aminobut-2-Enoate
|
|
21731-17-9
|
|
Dexrazoxane impurity 8
|
|
2084092-84-0
|
|
|
標(biāo)準(zhǔn)品RN1337
|
2162120-75-2
|
|
|
標(biāo)準(zhǔn)品RN1335
|
2306389-02-4
|
|
|
標(biāo)準(zhǔn)品RN1336
|
2409007-41-4
|
|
Gemcitabine EP Impurity B HCl
|
|
122111-05-1
|
|
Terazosin EP Impurity M
|
|
31350-27-3
|
|
Sulfamic Acid Methyl Ester
|
|
55665-95-7
|
|
1,3-di(pyridin-4-yl)urea
|
|
39642-87-0
|
|
Fosaprepitant impurity 3
|
|
265121-01-5
|
|
Avatrombopag impurity 26
|
|
2161380-87-4
|
|
Fusidic Acid EP Impurity J（ Sodium Fusidate EP Impurity J）
|
|
13011-12-6
|
|
Moxifloxacin impurity 16
|
|
2327019-81-6
|
|
(S)-Cetirizine
|
|
130018-76-7
|
|
VH032-NH-CO-CH2-NHBoc
|
|
2010986-19-1
|
|
1，2-bis(4，5-dihydrothiazol-2-yl)disulfane
|
|
2801-13-0
|
|
Norfloxacin EP Impurity H
|
|
105440-01-5
|
|
3-(1，3-dioxolan-2-yl)phenol
|
|
7070-85-1
|
|
Moxifloxacin impurity 26
|
|
161594-54-3
|
|
Levocetirizine Impurity 1
|
|
909779-33-5
|
|
Levocetirizine Impurity 11
|
|
70558-10-0
|
|
Sugammadex sodium Org199129-1 Impurity
|
|
2412953-06-9
|
|
Thalidomide-NH-(CH2)3-NH-Boc
|
|
2093386-36-6
|
|
Levetiracetam Impurity 8
|
|
4635-59-0
|
|
Aprepitant Impurity 2
|
|
171482-05-6
|
|
Atorvastatin EP Impurity K
|
|
345891-62-5
|
|
Terbutaline EP Impurity D
|
|
94109-61-2
|
|
Dexrazoxane impurity 12
|
|
120418-76-0
|
|
TD-106（3-(5-amino-4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)piperidine-2,6-dione）
|
|
2250288-69-6
|
|
Gemcitabine impurity 5
|
|
1258595-49-1
|
|
|
標(biāo)準(zhǔn)品RN1332
|
1448189-66-9
|
|
Fosaprepitant impurity 6
|
|
2514928-37-9
|
|
|
標(biāo)準(zhǔn)品RN1334
|
2412055-00-4
|
|
1，3-Dichloro-2-Methylpropane
|
|
616-19-3
|
|
Pitavastatin Impurity 3
|
|
154057-58-6
|
|
Ethyl (Z)-3-Aminobut-2-Enoate
|
|
626-34-6
|
|
Rapamycin impurity 5
|
|
500733-49-3
|
|
Gemcitabine impurity 4
|
|
866473-31-6
|
|
3-hydroxypiperidine-2-carboxylic acid
|
|
56879-47-1
|
|
Cholesta-3,5-dien-7-one
|
3,5-二烯膽甾-7-酮
|
567-72-6
|
|
Thalidomide-5-NH-CH2-COO(t-Bu)
|
|
2412056-28-9
|
|
|
標(biāo)準(zhǔn)品RN1331
|
2111829-84-4
|
|
Ethyl (E)-3-Ethoxybut-2-Enoate
|
|
57592-45-7
|
|
Fosaprepitant impurity 8
|
|
1523569-89-2
|
|
Thalidomide-NH-(CH2)2-NH2 TFA
|
|
1957235-67-4
|
|
Thalidomide-5-O-CH2-COOH
|
|
2467425-53-0
|
|
Levetiracetam EP Impurity C
|
|
142-08-5
|
|
picolinoyl chloride
|
|
29745-44-6
|
|
Terazosin EP Impurity N
|
|
63074-07-7
|
|
Vancomycin EP Impurity D
|
|
101485-50-1
|
|
Gemcitabine impurity 10
|
|
928797-50-6
|
|
Gemcitabine EP Impurity B
|
|
95058-85-8
|
|
Thalidomide-4-propargyl
|
|
2098487-39-7
|
|
Avatrombopag impurity 45
|
|
832088-14-9
|
|
|
標(biāo)準(zhǔn)品RN1339
|
2827750-25-2
|
|
Chlorphenamine EP Impurity C
|
|
20619-12-9
|
|
Avatrombopag impurity 5
|
|
123971-45-9
|
|
Medetomidine Impurity 8
|
|
190000-46-5
|
|
Fosaprepitant impurity 4
|
|
1523569-86-9
|
|
Dexrazoxane impurity 7
|
|
2084092-82-8
|
|
Formoterol Impurity 1
|
|
188690-82-6
|
|
Thalidomide-4-NH-PEG2-COO(t-Bu)
|
|
2140807-16-3
|
|
1-Phenylpropane-1，2-Diol
|
|
1855-09-0
|
|
Latamoxef impurity 13
|
|
65664-73-5
|
|
|
標(biāo)準(zhǔn)品RN1338
|
2827750-24-1
|
|
Betahistine Impurity 4
|
|
37445-98-0
|
|
VH032-NH-CO-CH2-Br
|
|
2379404-33-6
|
|
Thalidomide-5-O-CH2-COO(t-Bu)
|
|
2682112-10-1
|
|
Latamoxef impurity 9
|
|
64076-52-4
|
|
Fusidic Acid EP Impurity O（ Sodium Fusidate EP Impurity O）
|
|
13090-91-0
|
|
Thalidomide-NH-(CH2)2-NH-Boc
|
|
1957235-57-2
|
|
Thalidomide-4-NH-PEG1-COO(t-Bu)
|
|
2140807-19-6
|
|
Thalidomide-NH-CH2-COO(t-Bu)
|
|
2093386-23-1
|
|
Levocetirizine Impurity 12
|
|
109036-15-9
|